EVE-112 Vaginal Ring
Alternative Name: Etonogestrel (ENG) + Ethinyl Estradiol (EE) Vaginal Ring; EVE112
Description: A vaginal ring expected to be a bioequivalent to NuvaRing with a different release profile.
Product Details
User: Female
Hormonal: Yes
Delivery Method: Vaginal Ring
Duration Type: Short-acting
Dose: Etonogestrel: 5mg, ethinyl estradiol: 0.85mg
Active Pharmaceutical Ingredient (API): - etonogestrel
- ethinyl estradiol
- etonogestrel
- ethinyl estradiol
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: Evestra, Inc., Gedeon Richter Plc.
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Phase III
Active Development: Yes
Status Details: - Ongoing phase III clinical trial.
- Ongoing phase III clinical trial.
Additional Information
References: Evestra, Inc. website: http://evestra.com/index.htm
Clinical Trial: https://www.clinicaltrialsregister.eu/ctr-search/search?query=2016-00209...
Evestra, Inc. website: http://evestra.com/index.htm
Clinical Trial: https://www.clinicaltrialsregister.eu/ctr-search/search?query=2016-00209...